A Comparison of the Predictive Value of International Medullary Thyroid Carcinoma Grading System (IMTCGS) With That of Other Risk Factors in a Chinese Medullary Thyroid Carcinoma Cohort
Clinical Endocrinology · 2025-05 · 102 (5) · 589-599
DOI: 10.1111/cen.15195 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Endocrinology, online erschienen am 03.01.2025. Verfasst von Jiajia Ni und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Neuroendocrine, Thyroid Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: This work was supported by the National Natural Science Foundation of China (grant no.: 81972497)..
Abstract (Originalsprache)
Background
The International Medullary Thyroid Carcinoma Grading System (IMTCGS) was recently introduced in medullary thyroid carcinoma (MTC). This study aimed to assess the predictive value of the IMTCGS for disease response and survival, and compare its predictive ability with that of other traditional risk factors in a Chinese MTC cohort.
Methods
The data of 137 MTC patients undergoing initial surgery between January 2004 and June 2023 were included for analysis. Histologic features were reviewed by two pathologists. Kaplan‐Meier survival analysis and Cox proportional hazard model were performed to analyse the association between risk factors (including IMTCGS high vs low grade) and progression‐free survival (PFS) and disease‐specific survival (DSS). ROC analysis and Delong's test were used to compare the predictive ability of IMTCGS with that of other risk factors.
Results
Local recurrence, distant metastasis, and disease‐specific death were observed in 14/134 (10.45%), 3/134 (2.24%), and 6/137 (4.38%) MTC patients, respectively. IMTCGS, TNM stage, postoperative calcitonin, postoperative CEA, and vascular invasion were associated with PFS in Kaplan‐Meier survival analysis (all p < 0.05). Postoperative calcitonin was the only independent predictor for PFS in multivariate analysis (HR = 1.002, p = 0.002). ROC analysis and Delong's test showed that postoperative calcitonin had superior predictive value for structural recurrence than IMTCGS (AUC 0.90 vs. 0.64, p = 0.002). IMTCGS, TNM stage, and vascular invasion were associated with DSS in Kaplan−Meier survival analysis (both p < 0.05). In multivariate analysis, IMTCGS was the only independent predictor for DSS (HR = 11.23, p = 0.05). The AUC of IMTCGS was 0.81 ( p = 0.01) for disease‐specific death.
Conclusion
In this Chinese MTC cohort, IMTCGS was a powerful predictor of disease‐specific death, while postoperative calcitonin was a powerful predictor of structural recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Förderung
- This work was supported by the National Natural Science Foundation of China (grant no.: 81972497).
Zitieren
APA
Ni, J., Zhang, X., Liu, Y., & Ling, Y. (2025). A Comparison of the Predictive Value of International Medullary Thyroid Carcinoma Grading System (IMTCGS) With That of Other Risk Factors in a Chinese Medullary Thyroid Carcinoma Cohort. Clinical Endocrinology, 102(5), 589-599. https://doi.org/10.1111/cen.15195
Vancouver
Ni J, Zhang X, Liu Y, Ling Y. A Comparison of the Predictive Value of International Medullary Thyroid Carcinoma Grading System (IMTCGS) With That of Other Risk Factors in a Chinese Medullary Thyroid Carcinoma Cohort. Clinical Endocrinology. 2025;102(5):589-599. doi:10.1111/cen.15195
BibTeX
@article{Ni2025,
author = {Ni, Jiajia and Zhang, Xinyi and Liu, Yalan and Ling, Yan},
title = {A Comparison of the Predictive Value of International Medullary Thyroid Carcinoma Grading System (IMTCGS) With That of Other Risk Factors in a Chinese Medullary Thyroid Carcinoma Cohort},
journal = {Clinical Endocrinology},
year = {2025},
volume = {102},
number = {5},
pages = {589--599},
doi = {10.1111/cen.15195}
}
EUVIMED